CymitQuimica logo
HBV

HBV

Los inhibidores del VHB son compuestos diseñados para atacar e inhibir varias etapas del ciclo de vida del virus de la hepatitis B (VHB). Estos inhibidores pueden interferir con la replicación viral, el ensamblaje o la liberación, reduciendo así la carga viral y ayudando a manejar las infecciones crónicas por VHB. La investigación sobre inhibidores del VHB es crucial para desarrollar terapias antivirales efectivas que prevengan enfermedades hepáticas y cánceres asociados con el VHB. En CymitQuimica, ofrecemos una gama de inhibidores del VHB para apoyar su investigación en virología, desarrollo de medicamentos antivirales y gestión de enfermedades infecciosas.

Se han encontrado 185 productos de "HBV"

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • TLR7/8 agonist 13

    CAS:
    TLR7/8 agonist 13 is an orally active dual agonist of TLR7 (with a lowest effective concentration (LEC) [hTLR7] of 1.6 μM) and TLR8 (LEC [hTLR8] of 1.6 μM). It acts on human peripheral blood mononuclear cells (hPBMC) with agonistic activity (LEC [hPBMC] = 0.5 μM). In mice and cynomolgus monkeys, TLR7/8 agonist 13 induces endogenous IFNα, activates myeloid dendritic cells and monocytes, promoting their differentiation towards a TH1 phenotype. In chronic AAV-HBV mouse models, it reduces viral load and HBV surface antigen levels. TLR7/8 agonist 13 has the potential to indirectly induce IFNγ, facilitating the response of HBV antigen-specific CD8 T cells. This compound is useful for hepatitis B virus research.
    Fórmula:C12H22N4O2
    Forma y color:Solid
    Peso molecular:254.33

    Ref: TM-T212528

    10mg
    A consultar
    50mg
    A consultar
  • CCC-0975

    CAS:
    CCC-0975 is an inhibitor of hepatitis B virus (HBV) with an EC50 of 10 μM. It interferes with the conversion of relaxed circular DNA (rcDNA) to covalently closed circular DNA (cccDNA) and reduces cccDNA and its precursor deproteinized rcDNA (DP-rcDNA), without promoting their degradation inside cells. CCC-0975 holds potential for chronic hepatitis B research.
    Fórmula:C21H17ClF3N3O3S
    Forma y color:Solid
    Peso molecular:483.89

    Ref: TM-T210630

    10mg
    A consultar
    50mg
    A consultar
  • HBV-IN-34

    CAS:

    HBV-IN-34 (compound 17i) is a potent inhibitor of HBsAg production, demonstrating remarkable in vitro anti-HBV efficacy with EC50 values of 0.018 μM for HBV DNA

    Fórmula:C21H19F2N7
    Pureza:98%
    Forma y color:Solid
    Peso molecular:407.42

    Ref: TM-T79469

    5mg
    Descatalogado
    25mg
    Descatalogado
    50mg
    Descatalogado
    100mg
    Descatalogado
    Producto descatalogado
  • Yhhu6669

    CAS:

    Yhhu6669 is an anti-HBV agent that suppresses viral DNA and replication by promoting DNA-free capsid assembly, effectively reducing HBV DNA and HBcAg levels in

    Fórmula:C29H28ClFN6O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:563.02

    Ref: TM-T78756

    5mg
    Descatalogado
    25mg
    Descatalogado
    50mg
    Descatalogado
    100mg
    Descatalogado
    Producto descatalogado
  • HBV-IN-38

    CAS:

    HBV-IN-38 (Example 193), an HBV DNA inhibitor with an EC50 value of ≤100 nM, serves as a research tool for investigating viral infections [1].

    Fórmula:C18H16F3N5O4S2
    Pureza:98%
    Forma y color:Solid
    Peso molecular:487.48

    Ref: TM-T79879

    ne
    Descatalogado
    5mg
    Descatalogado
    50mg
    Descatalogado
    Producto descatalogado